PROPANC BIOPHARMA, INC.

Profile

Company Names

PROPANC BIOPHARMA, INC.
PROPANC HEALTH GROUP CORP

Addresses

302, 6 BUTLER STREET, CAMBERWELL, VIC, C3 3124

576 SWAN STREET, RICHMOND, C3 3121

Phone Numbers

613-9882-6723
61 3 9208 4182

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$8,064,935.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2023-10-20 
$40,000.00 
$40,000.00 
$0.00 
Debt 
13
2023-10-12 
$61,000.00 
$61,000.00 
$0.00 
Debt 
12
2023-08-23 
$72,500.00 
$72,500.00 
$0.00 
Debt 
11
2023-08-16 
$55,000.00 
$55,000.00 
$0.00 
Debt 
10
2023-08-15 
$120,000.00 
$120,000.00 
$0.00 
Debt 
9
2023-07-19 
$45,000.00 
$45,000.00 
$0.00 
Debt 
8
2023-06-29 
$65,000.00 
$65,000.00 
$0.00 
Debt 
7
2020-04-02 
$450,000.00 
$450,000.00 
$0.00 
Equity 
6
2018-12-24 
$126,000.00 
$126,000.00 
$0.00 
Debt 
5
2018-11-30 
$105,000.00 
$105,000.00 
$0.00 
Debt 
4
2018-10-02 
$422,000.00 
$422,000.00 
$0.00 
Debt 
3
2018-08-28 
$158,000.00 
$158,000.00 
$0.00 
Debt 
2
2016-09-13 
$6,315,435.00 
$6,315,435.00 
$0.00 
Debt 
1
2012-04-02 
$30,000.00 
$7,500,000.00 
$7,470,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CARLO 
 
CAMPICIANO 
EXECUTIVE OFFICER
PROPANC BIOPHARMA, INC.
JULIAN 
 
KENYON 
DIRECTOR, EXECUTIVE OFFICER
PROPANC HEALTH GROUP CORP   |  PROPANC BIOPHARMA, INC.
DOUGLAS 
 
MITCHELL 
EXECUTIVE OFFICER, DIRECTOR
PROPANC HEALTH GROUP CORP   |  CSBH LLC
JAMES 
 
NATHANIELSZ 
EXECUTIVE OFFICER, DIRECTOR
PROPANC HEALTH GROUP CORP   |  PROPANC BIOPHARMA, INC.
JOSEF 
 
ZELINGER 
DIRECTOR
PROPANC BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-11-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-10-20 
2023-10-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-10-12 
2023-08-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-08-23 
2023-08-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-08-16 
2023-08-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-08-15 
2023-08-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-06-29 
2023-08-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-07-19 
2020-04-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-04-02 
2019-01-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-12-24 
2019-01-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-11-30 
2018-10-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-10-02 
2018-10-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-09-13 
2018-09-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-08-28 
2012-06-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-04-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#